116
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

High rates of fatigue in newly diagnosed Graves' disease

, , , &
Pages 153-162 | Received 07 Apr 2014, Accepted 13 Jun 2014, Published online: 23 Jul 2014
 

Abstract

Background: Fatigue in patients with Graves’ disease has rarely been addressed. Purpose: To investigate the presence of subjective fatigue as well as cognitive fatigability among patients with untreated Graves' disease. Methods: Thirty-four patients (mean age: 39.2 ± 9.8) with newly diagnosed untreated Graves' disease and 31 healthy controls (mean age 36.7 ± 8.8) were investigated. The Digit Symbol Substitution Test was used for assessment of cognitive fatigability and the Fatigue Severity Scale (FSS) and the Everyday Consequences of Fatigue (ECF) questionnaire were used to assess self-rated effects of fatigue on activities and motivation. Results: Patients scored significantly higher on self-rated fatigue impact (FSS) than controls (p < 0.001) and 56% of patients reached a clinical level of fatigue impact. Half of the patients suffered from cognitive fatigability compared to 19% of the controls (p = 0.010). High free triiodothyronine (T3) levels were associated with ECF scores. Depression was associated with self-rated fatigue impact but not with cognitive fatigability. Free T3 correlated significantly with consequences of fatigue among the fatigued patients, while free T3 correlated significantly with incidental memory among the non-fatigued patients. Conclusions: The results suggest that both subjective fatigue impact and cognitive fatigability are common in untreated Graves' disease and that thyroid hormone levels might have differential effects on fatigue impact and memory in different individuals.

Acknowledgements

We thank Vibeke Bergmark, Anett Forsberg, Carina Ottosson, Alexandar Saric, Hugo Tellez, Anastasia Trouva, Sam Westdahl, and Emil Mikulski for data collection.

Funding

This study has been supported by the Centre for Clinical Research Sörmland, Uppsala University [82100].

Additional information

Notes on contributors

Marika C. Möller

Marika C. Möller is currently working at Kullbergska hospital, Department of Rehabilitation Medicine, Katrineholm, Sweden and Danderyd University Hospital, Department of Rehabilitation Medicine, Stockholm, Sweden.

Aniko Bartfai

Aniko Bartfai is currently working at Danderyd University Hospital, Department of Rehabilitation Medicine, Stockholm, Sweden.

Catharina Nygren de Boussard

Catharina Nygren de Boussard is currently working at Danderyd University Hospital, Department of Rehabilitation Medicine, Stockholm, Sweden.

Angelique Flöter Rådestad

Angelique Flöter Rådestad is currently working at Ersta Hospital, Division of Gynecology, Stockholm, Sweden.

Jan Calissendorff

Jan Calissendorff is currently working at Södersjukhuset, Endocrine section, Stockholm, Sweden.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.